[go: up one dir, main page]

AR004489A1 - Benzopiranos, su utilizacion para preparar medicamentos, las composiciones farmaceuticas que los contienen, los procedimientos para preparar dichos compuestos y compuestos intermediarios - Google Patents

Benzopiranos, su utilizacion para preparar medicamentos, las composiciones farmaceuticas que los contienen, los procedimientos para preparar dichos compuestos y compuestos intermediarios

Info

Publication number
AR004489A1
AR004489A1 ARP960102708A AR10270896A AR004489A1 AR 004489 A1 AR004489 A1 AR 004489A1 AR P960102708 A ARP960102708 A AR P960102708A AR 10270896 A AR10270896 A AR 10270896A AR 004489 A1 AR004489 A1 AR 004489A1
Authority
AR
Argentina
Prior art keywords
compounds
benzopyrans
preparing
pharmaceutical compositions
procedures
Prior art date
Application number
ARP960102708A
Other languages
English (en)
Original Assignee
Gosling Christopher David
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR004489(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gosling Christopher David filed Critical Gosling Christopher David
Publication of AR004489A1 publication Critical patent/AR004489A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Se describen derivados de benzopirano, en particular 2,2-dialquil C1-5 o trans-2,2-dialquil C1-5-3,4-dihidro-3-hidroxi-4-carboxamido-6-(N-arisulfonamido)-2H-1-benzopiranos; sus N-óxidos ésteres y sales; su utilización para preparar medicamentos,la s composiciones farmacéuticas que contienendichos compuestos y el procedimiento para prepararlos. Los compuestos actúan en la apertura del canal de potasio, son broncodilatadores y agentes para lasupresión de la hiperreactividad de las víasaéreas.
ARP960102708A 1995-05-24 1996-05-24 Benzopiranos, su utilizacion para preparar medicamentos, las composiciones farmaceuticas que los contienen, los procedimientos para preparar dichos compuestos y compuestos intermediarios AR004489A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds

Publications (1)

Publication Number Publication Date
AR004489A1 true AR004489A1 (es) 1998-12-16

Family

ID=10774940

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102708A AR004489A1 (es) 1995-05-24 1996-05-24 Benzopiranos, su utilizacion para preparar medicamentos, las composiciones farmaceuticas que los contienen, los procedimientos para preparar dichos compuestos y compuestos intermediarios

Country Status (30)

Country Link
US (1) US5905156A (es)
EP (1) EP0828733B1 (es)
JP (1) JPH11505820A (es)
KR (1) KR100437981B1 (es)
CN (1) CN1077888C (es)
AR (1) AR004489A1 (es)
AT (1) ATE205204T1 (es)
AU (1) AU703276B2 (es)
BR (1) BR9609048A (es)
CA (1) CA2217821C (es)
CO (1) CO4700520A1 (es)
CZ (1) CZ294474B6 (es)
DE (1) DE69615019T2 (es)
DK (1) DK0828733T3 (es)
ES (1) ES2163634T3 (es)
FI (1) FI973992A7 (es)
GB (1) GB9510477D0 (es)
HU (1) HU222772B1 (es)
IL (1) IL118382A (es)
MY (1) MY114924A (es)
NO (1) NO314846B1 (es)
NZ (1) NZ309765A (es)
PL (1) PL184144B1 (es)
PT (1) PT828733E (es)
RU (1) RU2160735C2 (es)
SK (1) SK283215B6 (es)
TR (1) TR199701417T1 (es)
TW (1) TW421646B (es)
WO (1) WO1996037490A1 (es)
ZA (1) ZA964209B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US6384244B2 (en) 2000-05-18 2002-05-07 Merck & Co., Inc. Process for preparing cis- aminochromanols
ATE486861T1 (de) * 2002-08-29 2010-11-15 Nissan Chemical Ind Ltd Verfahren zur herstellung einer aminobenzopyranverbindung
US7098340B2 (en) * 2003-05-14 2006-08-29 Warner Lambert Company Llc Benzyl sulfonamide derivatives
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
CA2999769A1 (en) 2015-09-28 2017-04-06 Genentech, Inc. Therapeutic compounds and methods of use thereof
CN106008288A (zh) * 2016-06-15 2016-10-12 西北农林科技大学 一种苯磺酰胺类化合物及其用途
CN110546148A (zh) * 2017-03-24 2019-12-06 基因泰克公司 作为钠通道抑制剂的4-哌啶-n-(嘧啶-4-基)色满-7-磺酰胺衍生物
TW202003490A (zh) 2018-05-22 2020-01-16 瑞士商赫孚孟拉羅股份公司 治療性化合物及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
GB9102803D0 (en) * 1991-02-11 1991-03-27 Ici Plc Pyridine compounds
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (es) * 1991-12-14 1995-04-01 Hoechst Ag
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
NO975365L (no) 1998-01-15
CA2217821C (en) 2008-05-06
AU703276B2 (en) 1999-03-25
GB9510477D0 (en) 1995-07-19
TR199701417T1 (xx) 1998-02-21
MX9709004A (es) 1998-03-31
PT828733E (pt) 2002-02-28
IL118382A (en) 2000-01-31
CN1077888C (zh) 2002-01-16
RU2160735C2 (ru) 2000-12-20
TW421646B (en) 2001-02-11
MY114924A (en) 2003-02-28
JPH11505820A (ja) 1999-05-25
HUP9801751A2 (hu) 1999-06-28
PL184144B1 (pl) 2002-09-30
FI973992A0 (fi) 1997-10-17
EP0828733B1 (en) 2001-09-05
NO314846B1 (no) 2003-06-02
DE69615019T2 (de) 2002-06-06
WO1996037490A1 (en) 1996-11-28
FI973992L (fi) 1997-12-09
PL324042A1 (en) 1998-05-11
KR19990021925A (ko) 1999-03-25
ATE205204T1 (de) 2001-09-15
CZ294474B6 (cs) 2005-01-12
KR100437981B1 (ko) 2004-07-16
ZA964209B (en) 1997-11-24
CN1185153A (zh) 1998-06-17
US5905156A (en) 1999-05-18
HK1014137A1 (en) 1999-09-24
CA2217821A1 (en) 1996-11-28
IL118382A0 (en) 1996-09-12
EP0828733A1 (en) 1998-03-18
ES2163634T3 (es) 2002-02-01
HUP9801751A3 (en) 1999-08-30
AU6000896A (en) 1996-12-11
SK157797A3 (en) 1998-05-06
CO4700520A1 (es) 1998-12-29
SK283215B6 (sk) 2003-03-04
DK0828733T3 (da) 2001-12-17
DE69615019D1 (de) 2001-10-11
NZ309765A (en) 2000-01-28
HU222772B1 (hu) 2003-10-28
FI973992A7 (fi) 1997-12-09
CZ368897A3 (cs) 1998-02-18
NO975365D0 (no) 1997-11-21
BR9609048A (pt) 1999-02-23

Similar Documents

Publication Publication Date Title
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
ES2084944T3 (es) Amidas terapeuticas.
AR006678A1 (es) Derivados de macrolidas triciclicas, una composicion farmaceutica que los contiene, uso de los mismos para preparar medicamentos y procedimientopara su preparacion
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
MX9300498A (es) Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
GT199700015A (es) Inhibidores de metaloproteinasa, composiciones farmaceuticas que las contienen y su uso farmaceutico y metodosyeficazproducto intermedio para su preparacion.
AR003427A1 (es) Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
AR007040A1 (es) Compuestos de eritromicina 6-0-sustituida, composiciones farmaceuticas, uso de dichos compuestos para preparar medicamentos y procedimiento para supreparacion
AR004489A1 (es) Benzopiranos, su utilizacion para preparar medicamentos, las composiciones farmaceuticas que los contienen, los procedimientos para preparar dichos compuestos y compuestos intermediarios
AR003984A1 (es) Composiciones antipruriticas, cosmeticas y/o farmaceuticas, procedimiento para su preparacion y empleo de dichas composiciones para la obtencion de unmedicamento.
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
MX9302420A (es) Derivados 3-arilpirazoles, procedimiento para su preparacion y composicion fungicida que los contiene.
ES2142030T3 (es) Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
AR015434A1 (es) Derivados de eritromicina con puente en 6,9, procedimientos para su preparacion, composicion farmaceutica para tratar infecciones bacterianas que los contiene y su uso para la manufactura de un medicamento
AR013079A1 (es) Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
ES2108422T3 (es) Combinaciones sinergicas de productos antisolares y composiciones cosmeticas y dermatologicas que las contienen.
PT98371A (pt) Processo para a preparacao de derivados 6-alcoxi de arabinofuranosil-guanina e de composicoes farmaceuticas que os contem
MX9400037A (es) Composicion oftalmica para el tratamiento de glaucoma e hipertension ocular.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.

Legal Events

Date Code Title Description
FG Grant, registration